Cargando…
ABO incompatible renal transplant: Transfusion medicine perspective
INTRODUCTION: Our study presents an analysis of the trends of ABO antibody titers and the TPE (Therapeutic Plasma Exchange) procedures required pre and post ABO incompatible renal transplant. MATERIALS AND METHODS: Twenty nine patients underwent ABO incompatible renal transplant during the study per...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5345280/ https://www.ncbi.nlm.nih.gov/pubmed/28316440 http://dx.doi.org/10.4103/0973-6247.200767 |
_version_ | 1782513684944257024 |
---|---|
author | Makroo, Raj Nath Nayak, Sweta Chowdhry, Mohit Jasuja, Sanjiv Sagar, Gaurav Rosamma, N. L. Thakur, Uday Kumar |
author_facet | Makroo, Raj Nath Nayak, Sweta Chowdhry, Mohit Jasuja, Sanjiv Sagar, Gaurav Rosamma, N. L. Thakur, Uday Kumar |
author_sort | Makroo, Raj Nath |
collection | PubMed |
description | INTRODUCTION: Our study presents an analysis of the trends of ABO antibody titers and the TPE (Therapeutic Plasma Exchange) procedures required pre and post ABO incompatible renal transplant. MATERIALS AND METHODS: Twenty nine patients underwent ABO incompatible renal transplant during the study period. The ABO antibody titers were done using the tube technique and titer reported was the dilution at which 1+ reaction was observed. The baseline titers of anti-A and anti-B antibodies were determined. The titer targeted was ≤8. Patients were subjected to 1 plasma volume exchange with 5% albumin and 2 units of AB group FFP (Fresh Frozen Plasma) in each sitting. TPE procedures post-transplant were decided on the basis of rising antibody titer with/ without graft dysfunction. RESULTS: The average number of TPE procedures required was 4-5 procedures/patient in the pretransplant and 2-3/patient in the post-transplant period. An average titer reduction of 1 serial dilution/procedure was noted for Anti-A and 1.1/procedure for Anti-B. Number of procedures required to reach the target titer was not significantly different for Anti-A and Anti-B (P = 0.98). Outcome of the transplant did not differ significantly by reducing titers to a level less than 8 (P = 0.32). The difference in the Anti-A and Anti-B titers at 14th day post-transplant was found to be clinically significant (P = 0.042). CONCLUSION: With an average of 4-5 TPE procedures pretransplant and 2-3 TPE procedures post transplants, ABO incompatible renal transplantations can be successfully accomplished. |
format | Online Article Text |
id | pubmed-5345280 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-53452802017-03-17 ABO incompatible renal transplant: Transfusion medicine perspective Makroo, Raj Nath Nayak, Sweta Chowdhry, Mohit Jasuja, Sanjiv Sagar, Gaurav Rosamma, N. L. Thakur, Uday Kumar Asian J Transfus Sci Original Article INTRODUCTION: Our study presents an analysis of the trends of ABO antibody titers and the TPE (Therapeutic Plasma Exchange) procedures required pre and post ABO incompatible renal transplant. MATERIALS AND METHODS: Twenty nine patients underwent ABO incompatible renal transplant during the study period. The ABO antibody titers were done using the tube technique and titer reported was the dilution at which 1+ reaction was observed. The baseline titers of anti-A and anti-B antibodies were determined. The titer targeted was ≤8. Patients were subjected to 1 plasma volume exchange with 5% albumin and 2 units of AB group FFP (Fresh Frozen Plasma) in each sitting. TPE procedures post-transplant were decided on the basis of rising antibody titer with/ without graft dysfunction. RESULTS: The average number of TPE procedures required was 4-5 procedures/patient in the pretransplant and 2-3/patient in the post-transplant period. An average titer reduction of 1 serial dilution/procedure was noted for Anti-A and 1.1/procedure for Anti-B. Number of procedures required to reach the target titer was not significantly different for Anti-A and Anti-B (P = 0.98). Outcome of the transplant did not differ significantly by reducing titers to a level less than 8 (P = 0.32). The difference in the Anti-A and Anti-B titers at 14th day post-transplant was found to be clinically significant (P = 0.042). CONCLUSION: With an average of 4-5 TPE procedures pretransplant and 2-3 TPE procedures post transplants, ABO incompatible renal transplantations can be successfully accomplished. Medknow Publications & Media Pvt Ltd 2017 /pmc/articles/PMC5345280/ /pubmed/28316440 http://dx.doi.org/10.4103/0973-6247.200767 Text en Copyright: © 2017 Asian Journal of Transfusion Science http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Makroo, Raj Nath Nayak, Sweta Chowdhry, Mohit Jasuja, Sanjiv Sagar, Gaurav Rosamma, N. L. Thakur, Uday Kumar ABO incompatible renal transplant: Transfusion medicine perspective |
title | ABO incompatible renal transplant: Transfusion medicine perspective |
title_full | ABO incompatible renal transplant: Transfusion medicine perspective |
title_fullStr | ABO incompatible renal transplant: Transfusion medicine perspective |
title_full_unstemmed | ABO incompatible renal transplant: Transfusion medicine perspective |
title_short | ABO incompatible renal transplant: Transfusion medicine perspective |
title_sort | abo incompatible renal transplant: transfusion medicine perspective |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5345280/ https://www.ncbi.nlm.nih.gov/pubmed/28316440 http://dx.doi.org/10.4103/0973-6247.200767 |
work_keys_str_mv | AT makroorajnath aboincompatiblerenaltransplanttransfusionmedicineperspective AT nayaksweta aboincompatiblerenaltransplanttransfusionmedicineperspective AT chowdhrymohit aboincompatiblerenaltransplanttransfusionmedicineperspective AT jasujasanjiv aboincompatiblerenaltransplanttransfusionmedicineperspective AT sagargaurav aboincompatiblerenaltransplanttransfusionmedicineperspective AT rosammanl aboincompatiblerenaltransplanttransfusionmedicineperspective AT thakurudaykumar aboincompatiblerenaltransplanttransfusionmedicineperspective |